Melatonin for the Early Treatment of COVID-19: A Narrative Review of Current Evidence and Possible Efficacy

DOI record: { "DOI": "10.1016/j.eprac.2021.06.001", "ISSN": [ "1530-891X" ], "URL": "http://dx.doi.org/10.1016/j.eprac.2021.06.001", "alternative-id": [ "S1530891X2101079X" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Melatonin for the Early Treatment of COVID-19: A Narrative Review of Current Evidence and Possible Efficacy" }, { "label": "Journal Title", "name": "journaltitle", "value": "Endocrine Practice" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.eprac.2021.06.001" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2021 AACE. Published by Elsevier Inc. All rights reserved." } ], "author": [ { "affiliation": [], "family": "Cross", "given": "Kristina M.", "sequence": "first" }, { "affiliation": [], "family": "Landis", "given": "Dylan M.", "sequence": "additional" }, { "affiliation": [], "family": "Sehgal", "given": "Laveena", "sequence": "additional" }, { "affiliation": [], "family": "Payne", "given": "J. Drew", "sequence": "additional" } ], "container-title": "Endocrine Practice", "container-title-short": "Endocrine Practice", "content-domain": { "crossmark-restriction": true, "domain": [ "aacejournalendocrinepractice.org", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2021, 6, 10 ] ], "date-time": "2021-06-10T08:28:14Z", "timestamp": 1623313694000 }, "deposited": { "date-parts": [ [ 2021, 8, 4 ] ], "date-time": "2021-08-04T06:52:24Z", "timestamp": 1628059944000 }, "indexed": { "date-parts": [ [ 2024, 5, 13 ] ], "date-time": "2024-05-13T08:32:21Z", "timestamp": 1715589141643 }, "is-referenced-by-count": 22, "issue": "8", "issued": { "date-parts": [ [ 2021, 8 ] ] }, "journal-issue": { "issue": "8", "published-print": { "date-parts": [ [ 2021, 8 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 8, 1 ] ], "date-time": "2021-08-01T00:00:00Z", "timestamp": 1627776000000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S1530891X2101079X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S1530891X2101079X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "850-855", "prefix": "10.1016", "published": { "date-parts": [ [ 2021, 8 ] ] }, "published-print": { "date-parts": [ [ 2021, 8 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1016/j.lfs.2020.117583", "article-title": "COVID-19: melatonin as a potential adjuvant treatment", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "117583", "journal-title": "Life Sci", "key": "10.1016/j.eprac.2021.06.001_bib1", "volume": "250", "year": "2020" }, { "DOI": "10.1080/17512433.2020.1814141", "article-title": "Melatonin as a putative protection against myocardial injury in COVID-19 infection", "author": "Simko", "doi-asserted-by": "crossref", "first-page": "921", "issue": "9", "journal-title": "Expert Rev Clin Pharmacol", "key": "10.1016/j.eprac.2021.06.001_bib2", "volume": "13", "year": "2020" }, { "DOI": "10.3390/molecules25194410", "article-title": "Targeting host defense system and rescuing compromised mitochondria to increase tolerance against pathogens by melatonin may impact outcome of deadly virus infection pertinent to COVID-19", "author": "Tan", "doi-asserted-by": "crossref", "first-page": "4410", "issue": "19", "journal-title": "Molecules", "key": "10.1016/j.eprac.2021.06.001_bib3", "volume": "25", "year": "2020" }, { "DOI": "10.1016/j.lfs.2020.117716", "article-title": "Correspondence COVID-19: melatonin as a potential adjuvant treatment", "author": "Salles", "doi-asserted-by": "crossref", "first-page": "117716", "journal-title": "Life Sci", "key": "10.1016/j.eprac.2021.06.001_bib4", "volume": "253", "year": "2020" }, { "DOI": "10.1002/jmv.24130", "article-title": "Ebola virus: melatonin as a readily available treatment option", "author": "Anderson", "doi-asserted-by": "crossref", "first-page": "537", "issue": "4", "journal-title": "J Med Virol", "key": "10.1016/j.eprac.2021.06.001_bib5", "volume": "87", "year": "2015" }, { "DOI": "10.1080/08830185.2020.1756284", "article-title": "Can melatonin reduce the severity of COVID-19 pandemic?", "author": "Shneider", "doi-asserted-by": "crossref", "first-page": "153", "issue": "4", "journal-title": "Int Rev Immunol", "key": "10.1016/j.eprac.2021.06.001_bib6", "volume": "39", "year": "2020" }, { "DOI": "10.1111/jpi.12186", "article-title": "Ebola virus disease: potential use of melatonin as a treatment", "author": "Tan", "doi-asserted-by": "crossref", "first-page": "381", "issue": "4", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib7", "volume": "57", "year": "2014" }, { "DOI": "10.1186/s13104-018-3417-3", "article-title": "Screening of melatonin, α-tocopherol, folic acid, acetyl-L-carnitine and resveratrol for anti-dengue 2 virus activity", "author": "Paemanee", "doi-asserted-by": "crossref", "first-page": "307", "issue": "1", "journal-title": "BMC Res Notes", "key": "10.1016/j.eprac.2021.06.001_bib8", "volume": "11", "year": "2018" }, { "DOI": "10.2174/0929867322666150827093730", "article-title": "Potential relevance of melatonin against some infectious agents: a review and assessment of recent research", "author": "Elmahallawy", "doi-asserted-by": "crossref", "first-page": "3848", "issue": "33", "journal-title": "Curr Med Chem", "key": "10.1016/j.eprac.2021.06.001_bib9", "volume": "22", "year": "2015" }, { "DOI": "10.1002/rmv.1714", "article-title": "Beneficial actions of melatonin in the management of viral infections: a new use for this “molecular handyman”?", "author": "Boga", "doi-asserted-by": "crossref", "first-page": "323", "issue": "5", "journal-title": "Rev Med Virol", "key": "10.1016/j.eprac.2021.06.001_bib10", "volume": "22", "year": "2012" }, { "DOI": "10.1111/jpi.12676", "article-title": "Melatonin restores neutrophil functions and prevents apoptosis amid dysfunctional glutathione redox system", "author": "Naveenkumar", "doi-asserted-by": "crossref", "issue": "3", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib11", "volume": "69", "year": "2020" }, { "DOI": "10.1002/rmv.2109", "article-title": "Melatonin: roles in influenza, Covid-19, and other viral infections", "author": "Anderson", "doi-asserted-by": "crossref", "first-page": "e2109", "issue": "3", "journal-title": "Rev Med Virol", "key": "10.1016/j.eprac.2021.06.001_bib12", "volume": "30", "year": "2020" }, { "DOI": "10.1186/1824-7288-39-61", "article-title": "Melatonin: its possible role in the management of viral infections--a brief review", "author": "Silvestri", "doi-asserted-by": "crossref", "first-page": "61", "journal-title": "Ital J Pediatr", "key": "10.1016/j.eprac.2021.06.001_bib13", "volume": "39", "year": "2013" }, { "DOI": "10.1111/j.1600-079X.2009.00733.x", "article-title": "Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice", "author": "Huang", "doi-asserted-by": "crossref", "first-page": "109", "issue": "2", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib14", "volume": "48", "year": "2010" }, { "DOI": "10.2174/187221412799015317", "article-title": "Melatonin in bacterial and viral infections with focus on sepsis: a review", "author": "Srinivasan", "doi-asserted-by": "crossref", "first-page": "30", "issue": "1", "journal-title": "Recent Pat Endocr Metab Immune Drug Discov", "key": "10.1016/j.eprac.2021.06.001_bib15", "volume": "6", "year": "2012" }, { "DOI": "10.1111/j.1601-0825.2009.01610.x", "article-title": "Melatonin in diseases of the oral cavity", "author": "Gómez-Moreno", "doi-asserted-by": "crossref", "first-page": "242", "issue": "3", "journal-title": "Oral Dis", "key": "10.1016/j.eprac.2021.06.001_bib16", "volume": "16", "year": "2010" }, { "article-title": "The reduced level of plasma melatonin in HFRS patients is correlated with disease severity and stage. Article in Chinese", "author": "Ma", "first-page": "1027", "issue": "11", "journal-title": "Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi", "key": "10.1016/j.eprac.2021.06.001_bib17", "volume": "34", "year": "2018" }, { "DOI": "10.1111/jpi.12124", "article-title": "Melatonin modulates the autophagic response in acute liver failure induced by the rabbit hemorrhagic disease virus", "author": "San-Miguel", "doi-asserted-by": "crossref", "first-page": "313", "issue": "3", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib18", "volume": "56", "year": "2014" }, { "DOI": "10.1111/jpi.12063", "article-title": "Melatonin treatment reduces endoplasmic reticulum stress and modulates the unfolded protein response in rabbits with lethal fulminant hepatitis of viral origin", "author": "Tuñón", "doi-asserted-by": "crossref", "first-page": "221", "issue": "3", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib19", "volume": "55", "year": "2013" }, { "DOI": "10.1111/j.1600-079X.2012.00995.x", "article-title": "Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin", "author": "Laliena", "doi-asserted-by": "crossref", "first-page": "270", "issue": "3", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib20", "volume": "53", "year": "2012" }, { "DOI": "10.1111/jpi.12335", "article-title": "Melatonin inhibits the sphingosine kinase 1/sphingosine-1-phosphate signaling pathway in rabbits with fulminant hepatitis of viral origin", "author": "Crespo", "doi-asserted-by": "crossref", "first-page": "168", "issue": "2", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib21", "volume": "61", "year": "2016" }, { "DOI": "10.1016/0165-5728(90)90059-V", "article-title": "The involvement of pineal gland and melatonin in immunity and aging. I. Thymus-mediated, immunoreconstituting and antiviral activity of thyrotropin-releasing hormone", "author": "Pierpaoli", "doi-asserted-by": "crossref", "first-page": "99", "issue": "2-3", "journal-title": "J Neuroimmunol", "key": "10.1016/j.eprac.2021.06.001_bib22", "volume": "27", "year": "1990" }, { "article-title": "Venezuelan equine encephalomyelitis", "author": "Walton", "first-page": "203", "key": "10.1016/j.eprac.2021.06.001_bib23", "series-title": "The Arboviruses: Epidemiology and Ecology", "year": "2019" }, { "DOI": "10.1023/A:1010964500370", "article-title": "High intensity light increases olfactory bulb melatonin in Venezuelan equine encephalitis virus infection", "author": "Medina-Leendertz", "doi-asserted-by": "crossref", "first-page": "231", "issue": "3", "journal-title": "Neurochem Res", "key": "10.1016/j.eprac.2021.06.001_bib24", "volume": "26", "year": "2001" }, { "DOI": "10.1023/A:1022897314108", "article-title": "Melatonin increases interleukin-1beta and decreases tumor necrosis factor alpha in the brain of mice infected with the Venezuelan equine encephalomyelitis virus", "author": "Bonilla", "doi-asserted-by": "crossref", "first-page": "681", "issue": "5", "journal-title": "Neurochem Res", "key": "10.1016/j.eprac.2021.06.001_bib25", "volume": "28", "year": "2003" }, { "DOI": "10.1177/2040206616660851", "article-title": "Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus", "author": "Montiel", "doi-asserted-by": "crossref", "first-page": "99", "issue": "3-4", "journal-title": "Antivir Chem Chemother", "key": "10.1016/j.eprac.2021.06.001_bib26", "volume": "24", "year": "2015" }, { "DOI": "10.1016/j.brainres.2015.06.034", "article-title": "Melatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental Venezuelan equine encephalitis", "author": "Valero", "doi-asserted-by": "crossref", "first-page": "368", "journal-title": "Brain Res", "key": "10.1016/j.eprac.2021.06.001_bib27", "volume": "1622", "year": "2015" }, { "DOI": "10.1016/j.actatropica.2014.04.021", "article-title": "Effects of melatonin on oxidative stress, and resistance to bacterial, parasitic, and viral infections: a review", "author": "Vielma", "doi-asserted-by": "crossref", "first-page": "31", "journal-title": "Acta Trop", "key": "10.1016/j.eprac.2021.06.001_bib28", "volume": "137", "year": "2014" }, { "DOI": "10.1007/BF01309858", "article-title": "Protective effects of melatonin in mice infected with encephalitis viruses", "author": "Ben-Nathan", "doi-asserted-by": "crossref", "first-page": "223", "issue": "2", "journal-title": "Arch Virol", "key": "10.1016/j.eprac.2021.06.001_bib29", "volume": "140", "year": "1995" }, { "DOI": "10.1016/S0035-9203(02)90121-5", "article-title": "Melatonin induces changes to serum cytokines in mice infected with the Venezuelan equine encephalomyelitis virus", "author": "Valero", "doi-asserted-by": "crossref", "first-page": "348", "issue": "3", "journal-title": "Trans R Soc Trop Med Hyg", "key": "10.1016/j.eprac.2021.06.001_bib30", "volume": "96", "year": "2002" }, { "DOI": "10.1007/s11064-006-9098-7", "article-title": "Melatonin decreases nitric oxide production, inducible nitric oxide synthase expression and lipid peroxidation induced by Venezuelan encephalitis equine virus in neuroblastoma cell cultures", "author": "Valero", "doi-asserted-by": "crossref", "first-page": "925", "issue": "7", "journal-title": "Neurochem Res", "key": "10.1016/j.eprac.2021.06.001_bib31", "volume": "31", "year": "2006" }, { "DOI": "10.2174/157016207780077020", "article-title": "A study of tryptophan metabolism via serotonin in ventricular cerebrospinal fluid in HIV-1 infection using a neuroendoscopic technique", "author": "Longatti", "doi-asserted-by": "crossref", "first-page": "267", "issue": "2", "journal-title": "Curr HIV Res", "key": "10.1016/j.eprac.2021.06.001_bib32", "volume": "5", "year": "2007" }, { "DOI": "10.3181/00379727-219-44327", "article-title": "Physical inactivity of murine retrovirus infected C57BL/6 mice is prevented by melatonin and dehydroepiandrosterone", "author": "Araghi-Niknam", "doi-asserted-by": "crossref", "first-page": "144", "issue": "2", "journal-title": "Proc Soc Exp Biol Med", "key": "10.1016/j.eprac.2021.06.001_bib33", "volume": "219", "year": "1998" }, { "DOI": "10.1159/000026345", "article-title": "Neuroimmunopathogenesis of ts1 MoMuLV viral infection", "author": "Lynn", "doi-asserted-by": "crossref", "first-page": "248", "issue": "5", "journal-title": "Neuroimmunomodulation", "key": "10.1016/j.eprac.2021.06.001_bib34", "volume": "5", "year": "1998" }, { "article-title": "Neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin in AIDS patients with CD4 cell number below 200/mm3: a biological phase-II study", "author": "Lissoni", "first-page": "155", "issue": "4", "journal-title": "J Biol Regul Homeost Agents", "key": "10.1016/j.eprac.2021.06.001_bib35", "volume": "9", "year": "1995" }, { "DOI": "10.2217/nnm-2020-0371", "article-title": "New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment", "author": "Martín Giménez", "doi-asserted-by": "crossref", "first-page": "2819", "issue": "29", "journal-title": "Nanomedicine (Lond)", "key": "10.1016/j.eprac.2021.06.001_bib36", "volume": "15", "year": "2020" }, { "DOI": "10.1111/jpi.12683", "article-title": "Clinical trial to test the efficacy of melatonin in COVID-19", "author": "Acuña-Castroviejo", "doi-asserted-by": "crossref", "issue": "3", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib37", "volume": "69", "year": "2020" }, { "DOI": "10.32794/mr11250064", "article-title": "High doses of melatonin as a potential therapeutic tool for the neurologic sequels of covid-19 infection", "author": "Cardinali", "doi-asserted-by": "crossref", "first-page": "311", "journal-title": "Melatonin Res", "key": "10.1016/j.eprac.2021.06.001_bib38", "volume": "3", "year": "2020" }, { "DOI": "10.1186/s41232-020-00146-3", "article-title": "How COVID-19 induces cytokine storm with high mortality", "author": "Hojyo", "doi-asserted-by": "crossref", "first-page": "37", "journal-title": "Inflamm Regen", "key": "10.1016/j.eprac.2021.06.001_bib39", "volume": "40", "year": "2020" }, { "DOI": "10.1155/2013/521783", "article-title": "The angiotensin-melatonin axis", "author": "Campos", "doi-asserted-by": "crossref", "first-page": "521783", "journal-title": "Int J Hypertens", "key": "10.1016/j.eprac.2021.06.001_bib40", "volume": "2013", "year": "2013" }, { "DOI": "10.1016/j.rbmo.2020.09.003", "article-title": "Clinical study of novel coronavirus pneumonia prevention by melatonin", "author": "Niu", "doi-asserted-by": "crossref", "first-page": "1156", "issue": "6", "journal-title": "Reprod Biomed Online", "key": "10.1016/j.eprac.2021.06.001_bib41", "volume": "41", "year": "2020" }, { "DOI": "10.3906/sag-2005-356", "article-title": "Melatonin, aging, and COVID-19: could melatonin be beneficial for COVID-19 treatment in the elderly?", "author": "Öztürk", "doi-asserted-by": "crossref", "first-page": "1504", "issue": "6", "journal-title": "Turk J Med Sci", "key": "10.1016/j.eprac.2021.06.001_bib42", "volume": "50", "year": "2020" }, { "DOI": "10.1016/j.virusres.2020.198108", "article-title": "Melatonin potentials against viral infections including COVID-19: current evidence and new findings", "author": "Juybari", "doi-asserted-by": "crossref", "first-page": "198108", "journal-title": "Virus Res", "key": "10.1016/j.eprac.2021.06.001_bib43", "volume": "287", "year": "2020" }, { "DOI": "10.1111/jpi.12525", "article-title": "Melatonin and inflammation-story of a double-edged blade", "author": "Hardeland", "doi-asserted-by": "crossref", "issue": "4", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib44", "volume": "65", "year": "2018" }, { "DOI": "10.7150/ijms.48053", "article-title": "COVID-19: rational discovery of the therapeutic potential of melatonin as a SARS-CoV-2 main protease inhibitor", "author": "Feitosa", "doi-asserted-by": "crossref", "first-page": "2133", "issue": "14", "journal-title": "Int J Med Sci", "key": "10.1016/j.eprac.2021.06.001_bib45", "volume": "17", "year": "2020" }, { "DOI": "10.1111/jpi.12162", "article-title": "Melatonin: a well-documented antioxidant with conditional pro-oxidant actions", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "131", "issue": "2", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib46", "volume": "57", "year": "2014" }, { "DOI": "10.3390/biom10091211", "article-title": "Melatonin’s impact on antioxidative and anti-inflammatory reprogramming in homeostasis and disease", "author": "Chitimus", "doi-asserted-by": "crossref", "first-page": "1211", "issue": "9", "journal-title": "Biomolecules", "key": "10.1016/j.eprac.2021.06.001_bib47", "volume": "10", "year": "2020" }, { "article-title": "Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone", "author": "Adamczyk-Sowa", "first-page": "235", "issue": "2", "journal-title": "J Physiol Pharmacol", "key": "10.1016/j.eprac.2021.06.001_bib48", "volume": "67", "year": "2016" }, { "DOI": "10.1016/j.lfs.2020.117739", "article-title": "Comment on melatonin as a potential adjuvant treatment for COVID-19", "author": "Herrera", "doi-asserted-by": "crossref", "first-page": "117739", "journal-title": "Life Sci", "key": "10.1016/j.eprac.2021.06.001_bib49", "volume": "253", "year": "2020" }, { "DOI": "10.1016/j.lfs.2020.117842", "article-title": "Crosstalk between endoplasmic reticulum stress and anti-viral activities: a novel therapeutic target for COVID-19", "author": "Banerjee", "doi-asserted-by": "crossref", "first-page": "117842", "journal-title": "Life Sci", "key": "10.1016/j.eprac.2021.06.001_bib50", "volume": "255", "year": "2020" }, { "DOI": "10.3390/nu12092561", "article-title": "Clinical trials for use of melatonin to fight against COVID-19 are urgently needed", "author": "Kleszczyński", "doi-asserted-by": "crossref", "first-page": "2561", "issue": "9", "journal-title": "Nutrients", "key": "10.1016/j.eprac.2021.06.001_bib51", "volume": "12", "year": "2020" }, { "DOI": "10.1038/s41577-020-0407-1", "article-title": "Tissue damage from neutrophil-induced oxidative stress in COVID-19", "author": "Laforge", "doi-asserted-by": "crossref", "first-page": "515", "issue": "9", "journal-title": "Nat Rev Immunol", "key": "10.1016/j.eprac.2021.06.001_bib52", "volume": "20", "year": "2020" }, { "DOI": "10.1007/s11033-020-05830-8", "article-title": "Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147)", "author": "Sehirli", "doi-asserted-by": "crossref", "first-page": "8229", "issue": "10", "journal-title": "Mol Biol Rep", "key": "10.1016/j.eprac.2021.06.001_bib53", "volume": "47", "year": "2020" }, { "DOI": "10.1111/j.1600-079X.1993.tb00478.x", "article-title": "The immunoneuroendocrine role of melatonin", "author": "Maestroni", "doi-asserted-by": "crossref", "first-page": "1", "issue": "1", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib54", "volume": "14", "year": "1993" }, { "article-title": "Elderly as a high-risk group during COVID-19 pandemic: effect of circadian misalignment, sleep dysregulation and melatonin administration", "author": "Cardinali", "first-page": "1", "journal-title": "Sleep Vigil", "key": "10.1016/j.eprac.2021.06.001_bib55", "year": "2020" }, { "DOI": "10.1111/j.1600-079X.2007.00538.x", "article-title": "Regression of herpes viral infection symptoms using melatonin and SB-73: comparison with acyclovir", "author": "Nunes Oda", "doi-asserted-by": "crossref", "first-page": "373", "issue": "4", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib56", "volume": "44", "year": "2008" }, { "DOI": "10.1211/002235702760345374", "article-title": "Melatonin: reducing the toxicity and increasing the efficacy of drugs", "author": "Reiter", "doi-asserted-by": "crossref", "first-page": "1299", "issue": "10", "journal-title": "J Pharm Pharmacol", "key": "10.1016/j.eprac.2021.06.001_bib57", "volume": "54", "year": "2002" }, { "DOI": "10.1186/s13063-021-05162-3", "article-title": "Evaluation of the effect of melatonin in patients with COVID-19-induced pneumonia admitted to the Intensive Care Unit: a structured summary of a study protocol for a randomized controlled trial", "author": "Ameri", "doi-asserted-by": "crossref", "first-page": "194", "issue": "1", "journal-title": "Trials", "key": "10.1016/j.eprac.2021.06.001_bib58", "volume": "22", "year": "2021" }, { "DOI": "10.1186/s13063-020-04632-4", "author": "Rodríguez-Rubio", "doi-asserted-by": "crossref", "first-page": "699", "issue": "1", "journal-title": "Trials", "key": "10.1016/j.eprac.2021.06.001_bib59", "volume": "21", "year": "2020" }, { "article-title": "Melatonin to reduce death toll due to COVID-19: from innate to adaptive immune response", "author": "Tesarik", "issue": "8", "journal-title": "Glob J Med Res: K Interdisciplinary", "key": "10.1016/j.eprac.2021.06.001_bib66", "volume": "20", "year": "2020" }, { "DOI": "10.1034/j.1600-079X.2003.00068.x", "article-title": "Urgent search for safe and effective treatments of severe acute respiratory syndrome: is melatonin a promising candidate drug?", "author": "Shiu", "doi-asserted-by": "crossref", "first-page": "69", "issue": "1", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib67", "volume": "35", "year": "2003" }, { "DOI": "10.1007/s40261-015-0368-5", "article-title": "The safety of melatonin in humans", "author": "Andersen", "doi-asserted-by": "crossref", "first-page": "169", "issue": "3", "journal-title": "Clin Drug Investig", "key": "10.1016/j.eprac.2021.06.001_bib68", "volume": "36", "year": "2016" }, { "DOI": "10.1034/j.1600-0633.2002.290401.x", "article-title": "Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment", "author": "Seabra", "doi-asserted-by": "crossref", "first-page": "193", "issue": "4", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib69", "volume": "29", "year": "2000" }, { "DOI": "10.1016/j.ejphar.2020.173329", "article-title": "Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19", "author": "El-Missiry", "doi-asserted-by": "crossref", "first-page": "173329", "journal-title": "Eur J Pharmacol", "key": "10.1016/j.eprac.2021.06.001_bib70", "volume": "882", "year": "2020" }, { "DOI": "10.1007/s100670050003", "article-title": "The effect of melatonin in patients with fibromyalgia: a pilot study", "author": "Citera", "doi-asserted-by": "crossref", "first-page": "9", "issue": "1", "journal-title": "Clin Rheumatol", "key": "10.1016/j.eprac.2021.06.001_bib71", "volume": "19", "year": "2000" }, { "DOI": "10.2174/092986710791233689", "article-title": "Clinical uses of melatonin: evaluation of human trials", "author": "Sánchez-Barceló", "doi-asserted-by": "crossref", "first-page": "2070", "issue": "19", "journal-title": "Curr Med Chem", "key": "10.1016/j.eprac.2021.06.001_bib72", "volume": "17", "year": "2010" }, { "DOI": "10.1016/j.sleep.2019.02.017", "article-title": "Efficacy and safety of melatonin for sleep onset insomnia in children and adolescents: a meta-analysis of randomized controlled trials", "author": "Wei", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "Sleep Med", "key": "10.1016/j.eprac.2021.06.001_bib73", "volume": "68", "year": "2020" }, { "DOI": "10.1111/jpi.12565", "article-title": "Melatonin pharmacokinetics and dose extrapolation after enteral infusion in neonates subjected to hypothermia", "author": "Balduini", "doi-asserted-by": "crossref", "issue": "4", "journal-title": "J Pineal Res", "key": "10.1016/j.eprac.2021.06.001_bib74", "volume": "66", "year": "2019" }, { "DOI": "10.1007/s40263-019-00680-w", "article-title": "Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: a systematic review", "author": "Besag", "doi-asserted-by": "crossref", "first-page": "1167", "issue": "12", "journal-title": "CNS Drugs", "key": "10.1016/j.eprac.2021.06.001_bib75", "volume": "33", "year": "2019" }, { "DOI": "10.1371/journal.pone.0240149", "article-title": "In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm", "author": "Artigas", "doi-asserted-by": "crossref", "issue": "10", "journal-title": "PLoS One", "key": "10.1016/j.eprac.2021.06.001_bib76", "volume": "15", "year": "2020" }, { "DOI": "10.1016/j.lfs.2020.117902", "article-title": "Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?", "author": "Simko", "doi-asserted-by": "crossref", "first-page": "117902", "journal-title": "Life Sci", "key": "10.1016/j.eprac.2021.06.001_bib78", "volume": "256", "year": "2020" } ], "reference-count": 71, "references-count": 71, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1530891X2101079X" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Melatonin for the Early Treatment of COVID-19: A Narrative Review of Current Evidence and Possible Efficacy", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "27" }